What is Cue?

Cue is a connected, molecular diagnostic system

The Cue Health Monitoring System is a fast, compact, highly portable testing platform with no compromise in performance or accuracy. It uses molecular diagnostic technology to deliver reliable results in about 20 minutes.

Who we work with

Cue is partnering with leading organizations such as BARDA, Henry Schein, Johnson & Johnson, Mayo Clinic, and the National Basketball Association to further our science and protect human health.


View all press

Cue’s Molecular, Point-of-Care COVID-19 Tests Now Available in 10 States Under Health and Human Services and…

Read more

Cue’s Molecular, Point-of-Care COVID-19 Tests Deployed to Five States in HHS and DOD Pilot Program

Read more

Cue’s CEO Ayub Khattak joins Lisa Ling on Season 2 of Johnson & Johnson’s COVID-19 Series: The Road to a Vaccine

Read more

Cue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million…

Read more

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19…

Read more

Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

Read more


One system, any industry

Accessible, accurate, scalable diagnostic testing for any industry, including healthcare, government, and education.

Who we are

Meet the team at Cue

We’re on a mission to transform how we detect disease and protect human health.

Made in the USA

Designed, engineered, manufactured, and tested in San Diego

Proudly headquartered in San Diego, Cue’s state-of-the-art space includes lab, office, and production facilities.